Feb. 8, 2018— Academic experts continue to question claims that the 340B drug discount program is the cause of consolidations of private physician practices and community-based hospitals. They argue the trend toward consolidation is much more complex and due to a series of factors, including changes in reimbursement policies. In the Feb. 8 issue of Forbes magazine, Duke … [Read more...]
Health Policy Experts Question Findings in Controversial NEJM Study
February 2, 2018—A team of independent health policy experts have questioned the major findings in a recent New England Journal of Medicine (NEJM) study critical of the 340B drug pricing program. In its Jan. 24 issue, the journal published a study authored by Sunita Desai, Ph.D., and J. Michael McWilliams, M.D., Ph.D., that raised questions about whether 340B hospitals are … [Read more...]
Flaws in Understanding Intent of 340B Program Lead to Incomplete Conclusions in Study
January 25, 2018—A recent study published in the New England Journal of Medicine (NEJM)[i] suggests that hospital use of the 340B program is “contrary to the goals of the program,” relying on a finding that there is no evidence of hospitals using 340B savings to expand care or lower mortality among low-income patients. This finding is inconsistent with existing research that … [Read more...]
Drug Companies May Owe Medicaid $1.3 Billion in Unpaid Rebates
January 3, 2018—Pharmaceutical companies may have misclassified 885 drugs for Medicaid drug rebate purposes in 2016, with the top 10 in terms of highest total reimbursement accounting for potentially $1.3 billion in lost Medicaid drug rebates, the U.S. Department of Health and Human Services Office of Inspector General (OIG) reports. Four drug manufacturers were responsible for … [Read more...]
Judge Lets CMS Impose Medicare Part B Cuts on 340B Hospitals Starting Jan. 1
December 30, 2017—U.S. District Judge Rudolph Contreras yesterday dismissed on procedural grounds the lawsuit to block a 28.5 percent reduction in 340B hospitals’ Medicare Part B drug reimbursement. The case was dismissed on the basis that hospitals have not yet presented a specific claim for reimbursement that has received the reduced payment rate. The decision left open the … [Read more...]
Judge to Rule by Jan. 1 in 340B Hospital Cuts Lawsuit
December 21, 2017—A federal district judge said today he will rule before the end of the year on whether the Centers for Medicare & Medicaid Services (CMS) can implement a regulation cutting $1.6 billion in Medicare drug reimbursement to 340B disproportionate share hospitals and rural referral centers effective Jan. 1. There “is a lot at stake” in the suit against CMS by … [Read more...]
Bipartisan Senate Group Asks Leaders to Help Block 340B Hospital Cuts
December 6, 2017—Efforts to block impending cuts to Medicare Part B payments to 340B hospitals gained momentum this week as a bipartisan group of six U.S. senators urged party leaders to enact legislation stopping the cuts before the end of December. The Dec. 5 letter from Sens. John Thune (R-S.D.), Rob Portman (R-Ohio), Shelley Moore Capito (R-W.Va.), Bill Nelson (D-Fla.), … [Read more...]